InterCure Bilan de santé
Santé financière contrôle des critères 3/6
InterCure has a total shareholder equity of ₪462.1M and total debt of ₪133.1M, which brings its debt-to-equity ratio to 28.8%. Its total assets and total liabilities are ₪740.9M and ₪278.8M respectively.
Informations clés
28.8%
Ratio d'endettement
₪133.07m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | ₪20.30m |
| Fonds propres | ₪462.12m |
| Total du passif | ₪278.77m |
| Total des actifs | ₪740.89m |
Mises à jour récentes de la santé financière
Recent updates
InterCure: A Cannabis Industry Leader Still Flying Under The Radar
Jun 30InterCure: Bargain Israel Cannabis Play
Apr 22InterCure: A Leader In Global Cannabis
Sep 06InterCure reports Q2 results
Aug 15InterCure Is Growing In The Massive Global Cannabis Market
Jun 07IntureCure: Israel Recreation Cannabis Boom On The Way
Feb 16InterCure Chairman Ehud Barak, CEO Alex Rabinovitch - Israel Cannabis And Beyond (Video)
Nov 08InterCure: Internationally Profitable Cannabis (Podcast Transcript)
Sep 19InterCure: Ignored Uplisting
Sep 09Analyse de la situation financière
Passif à court terme: INCR's short term assets (₪370.8M) exceed its short term liabilities (₪208.9M).
Passif à long terme: INCR's short term assets (₪370.8M) exceed its long term liabilities (₪69.9M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: INCR's net debt to equity ratio (24.4%) is considered satisfactory.
Réduire la dette: INCR's debt to equity ratio has increased from 5% to 28.8% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: Insufficient data to determine if INCR has enough cash runway based on its current free cash flow.
Prévisions de trésorerie: Insufficient data to determine if INCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.